Abdi İbrahim İlaç Sanayi ve Ticaret AŞ 2014 SR
The report highlights Abdi Ibrahim's sustainability performance and initiatives from 2013 to 2014. As the leader of the Turkish pharmaceutical sector, the company advanced its 2020 vision by investing in Turkey's largest biotechnological pharmaceutical production facility, AbdiBio. Abdi Ibrahim achieved significant environmental milestones, including reducing energy consumption by 35% per year since 2000 and saving 5,250 m3 of water in 2014. The company also demonstrated its commitment to social development through educational projects like the Belma Barut Primary School and cultural initiatives such as the renewal of the Sultan Bayezid II Health Museum.
Company: Abdi İbrahim İlaç Sanayi ve Ticaret AŞ
Country: Turkey
Year: 2014
Type: SR
Pages: 138
Back to company
Abdi İbrahim İlaç Sanayi ve Ticaret AŞ
Sustainability Report
The report highlights Abdi Ibrahim's sustainability performance and initiatives from 2013 to 2014. As the leader of the Turkish pharmaceutical sector, the company advanced its 2020 vision by investing in Turkey's largest biotechnological pharmaceutical production facility, AbdiBio. Abdi Ibrahim achieved significant environmental milestones, including reducing energy consumption by 35% per year since 2000 and saving 5,250 m3 of water in 2014. The company also demonstrated its commitment to social development through educational projects like the Belma Barut Primary School and cultural initiatives such as the renewal of the Sultan Bayezid II Health Museum.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Jan 1, 2013 - Dec 31, 2014
Fiscal Year
2014
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Renewable Energy
Water Consumption
Employees